Delivery Order SPE2DB22D3016-SPE2DB25FBKQ6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml on June 18, 2025, with a ceiling value of $1,103.20 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with performance scheduled to conclude by June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,127.10 to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml, a controlled pharmaceutical used in pain management and palliative care. Issued on July 21, 2025, with an ultimate completion date of July 22, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Hydromorphone 1 mg/mL vials with a ceiling value of $2,942.66. This is a firm fixed price, non-competitive delivery order with a completion date of August 22, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $1,348.21 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100-count supply) with a completion date of July 28, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.88 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Hydromorphone 2 mg/ml, a narcotic pain management pharmaceutical. This firm fixed-price delivery order, which is expected to be completed by August 29, 2025, carries no set-aside designation and represents a competitively awarded transaction under open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.20 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Hydromorphone HCL ER Tablets 16mg, with a contract ceiling value of $6,259.66 and a completion date of August 5, 2025. This competitive award, made without set-aside designation, is classified as a firm fixed price delivery order and represents a continuation of the federal government's ongoing pharmaceutical procurement through established...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at approximately $1,914.70 to Amerisourcebergen Drug Corporation for 4561778548 HYDROMORPHONE 1ML 10S. The place of performance will be Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 11, 2023 through August 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.00 firm fixed-price contract is for the supply of 4567466725 ! HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,216.32, is for the procurement of 4567234220 - HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKQ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,258.29 to AmerisourceBergen Drug Corp for the supply of Hydromorphone 0.5 mg/0.5 mL injectable solution. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The delivery order for Hydromorphone represents a routine pharmaceutical supply requirement under this expansive vehicle designed to support military medical operations and healthcare delivery programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/23/25 |